Cannabinoids in the Management of Musculoskeletal Pain: A Critical Review of the Evidence

JBJS Rev. 2018 May;6(5):e7. doi: 10.2106/JBJS.RVW.17.00153.

Authors

Kim Madden¹, Niek van der Hoek², Simrun Chona³, Annie George³, Tristiana Dalchand⁴, Hassan Baldawi¹, George Mammen^{5

6}, Mohit Bhandari¹

Affiliations

¹ Departments of Health Research Methods (K.M. and M.B.) and Surgery (H.B. and M.B.), McMaster University, Hamilton, Ontario, Canada.
² Department of Medicine, University of Groningen, Groningen, the Netherlands.
³ OrthoEvidence, Inc., Burlington, Ontario, Canada.
⁴ University of Toronto, Toronto, Ontario, Canada.
⁵ Institute for Mental Health Policy Research, Toronto, Ontario, Canada.
⁶ Beleave, Inc., Hamilton, Ontario, Canada.

PMID: 29787450
DOI: 10.2106/JBJS.RVW.17.00153

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Systematic Review

MeSH terms

Analgesics, Opioid / therapeutic use*
Cancer Pain / drug therapy*
Cannabinoids / therapeutic use*
Evidence-Based Medicine
Humans
Musculoskeletal Diseases / complications
Musculoskeletal Diseases / drug therapy*
Musculoskeletal Diseases / physiopathology
Musculoskeletal Pain / drug therapy*
Treatment Outcome

Substances

Analgesics, Opioid
Cannabinoids

Grants and funding

GSD-13492/CIHR/Canada